Skip to main content

Current Issue

Original Research
02/19/2026
Alexandrina Balanean, MPH, MWC; Yolaine J. Jeune-Smith, PhD; Parisa Asgarisabet, PhD, MBA; Camryn Craig, BS; Harlen Hays, MPH; JaLyna Laney, RN, OCN; Ajeet Gajra, MD, FACP; Bruce A. Feinberg, DO
Evidence from a national cohort study highlights significant survival and treatment disparities among patients with uterine cancer, pointing to clinical pathways as a potential strategy to advance equity and improve outcomes.
Evidence from a national cohort study highlights significant survival and treatment disparities among patients with uterine cancer, pointing to clinical pathways as a potential strategy to advance equity and improve outcomes.
Evidence from a national cohort...
02/19/2026
Journal of Clinical Pathways
Letter from the Editor
02/17/2026
Alan J. Balch, PhD, MSc
Editor-in-Chief Alan Balch, PhD, MSc, discusses how cost pressures, equity gaps, and evolving employer and policy dynamics demand that evidence-based care be aligned not only with clinical rigor, but with value and real-world impact.
Editor-in-Chief Alan Balch, PhD, MSc, discusses how cost pressures, equity gaps, and evolving employer and policy dynamics demand that evidence-based care be aligned not only with clinical rigor, but with value and real-world impact.
Editor-in-Chief Alan Balch, PhD,...
02/17/2026
Journal of Clinical Pathways
Original Research
02/17/2026
Christopher J. Ferreri, MD; Peter M. Voorhees, MD; Marvin Knight; Meaghan Roach, MPH; Richard Murphy, BA; Amal Jamaleddine, BA; Nicole Bariahtaris, BA; Cindy Varga, MD
This study demonstrates how a Hospital-at-Home–supported outpatient model can safely deliver step-up dosing of teclistamab and talquetamab for selected patients with relapsed/refractory multiple myeloma.
This study demonstrates how a Hospital-at-Home–supported outpatient model can safely deliver step-up dosing of teclistamab and talquetamab for selected patients with relapsed/refractory multiple myeloma.
This study demonstrates how a...
02/17/2026
Journal of Clinical Pathways
ONLINE EXCLUSIVES
02/10/2026
Gordon Kuntz; Bryan Loy, MD, MBA
This Online Exclusive features the debut episode of The Pathways Guys podcast, a series exploring the real-world impact of clinical pathways on oncology policy, payment, and practice.
This Online Exclusive features the debut episode of The Pathways Guys podcast, a series exploring the real-world impact of clinical pathways on oncology policy, payment, and practice.
This Online Exclusive features...
02/10/2026
Journal of Clinical Pathways
Transformative Business Trends
02/10/2026
F. Randy Vogenberg, PhD, FASHP
This column discusses how shifting federal policy, employer health plan economics, and rising drug costs in 2026 will reshape business decisions that directly influence oncology access, affordability, and clinical pathway sustainability.
This column discusses how shifting federal policy, employer health plan economics, and rising drug costs in 2026 will reshape business decisions that directly influence oncology access, affordability, and clinical pathway sustainability.
This column discusses how...
02/10/2026
Journal of Clinical Pathways
Author